News: Year - 2017

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – March 27, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on March 27, 2017, it issued 80,251 common shares of the Corporation (“Common Shares”) in payment of $12,439 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces Completion of Share Consolidation

WINNIPEG, Manitoba – March 10, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that, further to the approval by the Corporation’s shareholders obtained on December 16, 2016, the Corporation has completed the consolidation of its…

> Read More

Press Releases
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra

WINNIPEG, Manitoba – March 6, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce that it has entered into an exclusive license and distribution agreement (the “License Agreement”) with Dechra Veterinary Products LLC (“Dechra”),…

> Read More